Agilent Technologies Inc vs Energy Select Sector SPDR Fund — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Energy Select Sector SPDR Fund trades at $60.96. The key difference: Agilent Technologies Inc pays a 0.69% dividend while Energy Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| A | XLE | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | — |
52-Week High | $157.20 | $62.57 |
52-Week Low | $110.24 | $42.33 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
XLE (Energy Select Sector SPDR ETF) trades at $57.48, down 1.17% amid bearish technical signals. The ETF faces headwinds despite strong energy sector performance driven by geopolitical tensions and elevated oil prices. Recent earnings from major holdings like ExxonMobil and Chevron showed profit surges, but technical indicators suggest near-term weakness with resistance at $58 and support at $57.
Outlook remains mixed with geopolitical risks supporting oil prices but technical weakness suggesting caution. The concentrated exposure to major energy companies provides stability but limits diversification. Key risks include oil price volatility and Middle East tensions, while the low expense ratio of 0.08% maintains cost efficiency for long-term energy exposure.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →